USPTO serial 79284565
CELLPROTHERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- BELL, MARLENE D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CELLPROTHERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet G Ricciuti
Janet G Ricciuti JANET GILBERT RICCIUTI1830 S STREET NWWASHINGTON, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for cell cultures, cell culture media, culture media for cell growth for medical biotechnology, biological reagents for molecular biology, chemical reagents for medical use for biological processes, carriers of culture media for medical use, cellular function activating agents, serums, antibodies, all these products being for medical use | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical devices in the nature of human and animal cell, stem cells and cell-derived products and instruments for injection of cell, stem cells and cell-derived products, namely, chambers for culture, centrifugation and isolation of cell, stem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culture, namely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culture, namely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniques, namely, medical device and apparatus for human and animal cell selection, for human cell immune and for cell dimension selection for the cell-based diagnosis and treatment | ACTIVE | — |
| 042 | Research and development services of new products in the field of biotechnology, scientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties | ACTIVE | — |
| 044 | Services for medical care and treatment, namely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growth, sampling and isolation for the production of cell and cell-derived human and animal cell products, namely, cell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individuals, namely, behavioral analysis for medical purposes, therapeutic treatment, namely cell therapy for regenerative medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLPROTHERA
- Other trademarks owned by CELLPROTHERA
- Other trademarks owned by CELLPROTHERA
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELLPROTHERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 10, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 6, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 6, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 18, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 18, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 8, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 8, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 4, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 4, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2020 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |